Clinical Trials
17 trialsNCT03151629 2026-05-22
IRONMAN
Prostate Cancer Clinical Trials Consortium
Recruiting
NCT07602504 2026-05-22
China Metastatic Liver Cancer Clinical Registry Cohort Database
Anhui Provincial Hospital
Recruiting
NCT04751396 2026-05-20
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
Recruiting
NCT07563595 2026-05-04
ELENI
iOMEDICO AG
Not yet recruiting
NCT05733091 2026-04-21
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
M.D. Anderson Cancer Center
Recruiting
NCT05387512 2026-04-06
Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Affiliated Hospital of Nantong University
Completed
NCT07512921 2026-04-06
BIOMATCH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT05574673 2026-02-27
HERO
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Recruiting
NCT03997162 2026-02-24
Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery
City of Hope Medical Center
Active not recruiting
NCT07184047 2026-02-20
TOX-FRAIL
Ankara Etlik City Hospital
Completed
NCT05205343 2026-02-04
Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers
M.D. Anderson Cancer Center
Recruiting
NCT06089083 2026-01-26
PROOF
University of California, San Francisco
Recruiting
NCT05377320 2025-10-14
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
Not yet recruiting
NCT05754658 2025-10-06
African Cancer Genome: GMD
Fox Chase Cancer Center
Recruiting
NCT07057232 2025-07-14
PainSomnia
Germans Trias i Pujol Hospital
Recruiting
NCT06504524 2025-06-27
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Pfizer
Completed
NCT03158818 2025-06-10
HUTCH
University of Alabama at Birmingham
Active not recruiting